BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27464733)

  • 1. M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma.
    Shen L; Li H; Shi Y; Wang D; Gong J; Xun J; Zhou S; Xiang R; Tan X
    Sci Rep; 2016 Jul; 6():30347. PubMed ID: 27464733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legumain, an asparaginyl endopeptidase, mediates the effect of M2 macrophages on attenuating renal interstitial fibrosis in obstructive nephropathy.
    Wang D; Xiong M; Chen C; Du L; Liu Z; Shi Y; Zhang M; Gong J; Song X; Xiang R; Liu E; Tan X
    Kidney Int; 2018 Jul; 94(1):91-101. PubMed ID: 29656902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legumain Promotes Atherosclerotic Vascular Remodeling.
    Ozawa N; Sato Y; Mori Y; Masuda H; Yamane M; Yamamoto Y; Shirai R; Watanabe R; Sato K; Mori Y; Hirano T; Watanabe T
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
    Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
    Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells.
    Morita Y; Araki H; Sugimoto T; Takeuchi K; Yamane T; Maeda T; Yamamoto Y; Nishi K; Asano M; Shirahama-Noda K; Nishimura M; Uzu T; Hara-Nishimura I; Koya D; Kashiwagi A; Ohkubo I
    FEBS Lett; 2007 Apr; 581(7):1417-24. PubMed ID: 17350006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legumain promotes fibrogenesis in chronic pancreatitis via activation of transforming growth factor β1.
    Ren YC; Zhao Q; He Y; Li B; Wu Z; Dai J; Wen L; Wang X; Hu G
    J Mol Med (Berl); 2020 Jun; 98(6):863-874. PubMed ID: 32415356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.
    Wang J; Gao K; Lei W; Dong L; Xuan Q; Feng M; Wang J; Ye X; Jin T; Zhang Z; Zhang Q
    Oncotarget; 2017 Jan; 8(3):5414-5425. PubMed ID: 28036275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse large B cell lymphoma-derived extracellular vesicles educate macrophages to promote tumours progression by increasing PGC-1β.
    Liu W; Zhu M; Wang H; Wang W; Lu Y
    Scand J Immunol; 2020 Feb; 91(2):e12841. PubMed ID: 31833575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis.
    Cioroianu AI; Stinga PI; Sticlaru L; Cioplea MD; Nichita L; Popp C; Staniceanu F
    Anal Cell Pathol (Amst); 2019; 2019():8586354. PubMed ID: 31934533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group.
    Wada N; Zaki MA; Hori Y; Hashimoto K; Tsukaguchi M; Tatsumi Y; Ishikawa J; Tominaga N; Sakoda H; Take H; Tsudo M; Kuwayama M; Morii E; Aozasa K;
    Histopathology; 2012 Jan; 60(2):313-9. PubMed ID: 22211289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas.
    Kwon D; Kim S; Kim PJ; Go H; Nam SJ; Paik JH; Kim YA; Kim TM; Heo DS; Kim CW; Jeon YK
    Histopathology; 2016 Jun; 68(7):1079-89. PubMed ID: 26426431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legumain expression, activity and secretion are increased during monocyte-to-macrophage differentiation and inhibited by atorvastatin.
    Solberg R; Smith R; Almlöf M; Tewolde E; Nilsen H; Johansen HT
    Biol Chem; 2015 Jan; 396(1):71-80. PubMed ID: 25205715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis.
    Lewēn S; Zhou H; Hu HD; Cheng T; Markowitz D; Reisfeld RA; Xiang R; Luo Y
    Cancer Immunol Immunother; 2008 Apr; 57(4):507-15. PubMed ID: 17786443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and prognostic value of regulatory T cells and M2 macrophages in diffuse large B-cell lymphoma tissues].
    Xu YL; Wang HQ; Qian ZZ; Song Z; Zhou SY; Zhang HL; Qiu LH; Wang XH; Wang P
    Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):450-5. PubMed ID: 24119906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 4-induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma.
    Wang X; Li X; Zhang X; Zang L; Yang H; Zhao W; Zhao H; Li Q; Xia B; Yu Y; Wang Y; Zhao Z; Zhang Y
    Ann Diagn Pathol; 2015 Aug; 19(4):232-8. PubMed ID: 26071054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma.
    Marchesi F; Cirillo M; Bianchi A; Gately M; Olimpieri OM; Cerchiara E; Renzi D; Micera A; Balzamino BO; Bonini S; Onetti Muda A; Avvisati G
    Hematol Oncol; 2015 Jun; 33(2):110-2. PubMed ID: 24711044
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages.
    Linde N; Lederle W; Depner S; van Rooijen N; Gutschalk CM; Mueller MM
    J Pathol; 2012 May; 227(1):17-28. PubMed ID: 22262122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targeting.
    Haugen MH; Boye K; Nesland JM; Pettersen SJ; Egeland EV; Tamhane T; Brix K; Maelandsmo GM; Flatmark K
    Eur J Cancer; 2015 Jan; 51(1):9-17. PubMed ID: 25466510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.
    Wang H; Wang A; Hu Z; Xu X; Liu Z; Wang Z
    Cancer Immunol Res; 2016 Apr; 4(4):337-44. PubMed ID: 26865454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.